Search clinical trials for: carboplatin paclitaxel bevacizumab
Total 8284 results
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States, France, Hungary, Australia, Brazil, Canada, Spain, Germany, United Kingdom, Chile, Israel, Italy, Netherlands, Argentina, Ukraine, Russian Federation
-
Chinese PLA General HospitalUnknown
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Celgene CorporationCompletedNon-small Cell Lung CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
MedImmune LLCCompletedAdvanced Solid Tumors | Advanced Recurrent Ovarian TumorsUnited States
-
HiberCell, Inc.CompletedNon-Small Cell Lung CancerUnited States, Germany
-
Grupo de Investigación y Divulgación OncológicaUnknownNon-small Cell Lung Cancer (NSCLC)Spain
-
National Cancer Institute (NCI)TerminatedBreast Carcinoma | Stage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
TransgeneTerminatedNon-Small-Cell Lung CarcinomaUnited States, France, Hungary, United Kingdom, Spain, Israel, Belgium, Germany, Poland, Italy
-
Hoffmann-La RocheTerminated
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerAustralia, United States, Hungary, France, Germany, Czech Republic, Poland
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Netherlands
-
David O'MalleyGenentech, Inc.UnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | No Prior ChemotherapyUnited States
-
Hellenic Oncology Research GroupCompletedNon Small Cell Lung CancerGreece
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, Taiwan, United Kingdom, Philippines, Latvia, Italy, Israel, Argentina, Mexico, Germany, Malaysia
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
Milton S. Hershey Medical CenterTerminatedNon-small Cell Lung CancerUnited States
-
Cipla BioTec Pvt. Ltd.UnknownNon-Small Cell Lung Carcinoma
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedCarcinomaUnited States
-
AmgenGenentech, Inc.Completed
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Sweden, Hong Kong, Canada, Switzerland, Estonia, Greece, Russian Federation, Hungary, Austria, Bulgaria, Netherlands, Latvia, Italy, Slovenia, Turkey, Serbia, Israel, Argentina, Brazil, Slovakia, Lithuania, Poland, Portugal, Mexi... and more
-
Massachusetts General HospitalWomen and Infants Hospital of Rhode IslandCompletedOvarian Cancer
-
Boehringer IngelheimCompleted
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
M.D. Anderson Cancer CenterBayerCompletedLung CancerUnited States
-
Sun Yat-sen UniversityUnknownNasopharyngeal NeoplasmsChina
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung Cancer (NSCLC)United States, Brazil, Poland, Russian Federation, South Africa, France, Italy, United Kingdom
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung CancerUnited States
-
Duke UniversityGenentech, Inc.; Celgene CorporationCompletedBreast CancerUnited States
-
Mateon TherapeuticsCompleted
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerFrance
-
Karl KölbeckUnknownNon-small Cell Lung CancerSweden
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage II Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung CancerUnited States
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedNeoplasm, Unknown PrimaryUnited States
-
BayerCompletedCarcinoma, Non-Small-Cell Lung | Lung CancerUnited States
-
PfizerCompletedAdenocarcinoma | Non-Small-Cell Lung CarcinomaUnited States, Spain, Poland, Czech Republic, United Kingdom, France
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedBreast CancerUnited States
-
Medical Research CouncilCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerFrance, Australia, United Kingdom, Norway, Germany
-
Washington University School of MedicineWithdrawnCarcinoma, Non-Small-Cell Lung
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
Chinese PLA General HospitalUnknownOvarian Cancer With Malignant AscitesChina
-
Spanish Lung Cancer GroupCompletedNonsquamous Nonsmall Cell Neoplasm of LungSpain
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerAustralia, Germany, United States
-
University of ChicagoNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Drug/Agent Toxicity by Tissue/Organ | Adenosquamous Cell Lung Cancer | Hemoptysis